As the concerns over the efficiency of vaccines against the new variant emerges BioNTech says it can update the version of its vaccine within 100 days if Omicron, the new variant first detected in southern Africa, is found to reduce existing immunity.
The company says it will not just produce but also ship it in the timeline.
Investigations are already on to know that the vaccine which has been developed by the German biotechnology company; in association with US drugmaker Pfizer, works well against the variant or not.
Omicron has caused concern as it also has high number of mutations. It seems to have been transmitting more quickly as well.
According to the company, it will ascertain in two weeks on the basis of lab-based experiments; that its current vaccine is still effective against the B.1.1.529 variant; which has been named Omicron by the World Health Organization.
To make it more efficient against the new variant, BioNTech said it can tweak its vaccine if required.